Home/Filings/4/0001209191-20-063839
4//SEC Filing

Do Hung 4

Accession 0001209191-20-063839

CIK 0001178879other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 5:15 PM ET

Size

5.3 KB

Accession

0001209191-20-063839

Insider Transaction Report

Form 4
Period: 2020-12-14
Do Hung
Sr Vice President Discovery
Transactions
  • Sale

    Common Stock

    2020-12-14$23.88/sh111,125$2,653,276409,682 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $22.385 to $24.60 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001593353

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:15 PM ET
Size
5.3 KB